Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity
Simone Dertschnig, … , Clare L. Bennett, Ronjon Chakraverty
Simone Dertschnig, … , Clare L. Bennett, Ronjon Chakraverty
Published January 9, 2020
Citation Information: J Clin Invest. 2020;130(4):1896-1911. https://doi.org/10.1172/JCI133102.
View: Text | PDF
Research Article Autoimmunity

Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity

  • Text
  • PDF
Abstract

Acute graft-versus-host disease (GVHD) is initially triggered by alloreactive T cells, which damage peripheral tissues and lymphoid organs. Subsequent transition to chronic GVHD involves the emergence of autoimmunity, although the underlying mechanisms driving this process are unclear. Here, we tested the hypothesis that acute GVHD blocks peripheral tolerance of autoreactive T cells by impairing lymph node (LN) display of peripheral tissue–restricted antigens (PTAs). At the initiation of GVHD, LN fibroblastic reticular cells (FRCs) rapidly reduced expression of genes regulated by DEAF1, an autoimmune regulator-like transcription factor required for intranodal expression of PTAs. Subsequently, GVHD led to the selective elimination of the FRC population, and blocked the repair pathways required for its regeneration. We used a transgenic mouse model to show that the loss of presentation of an intestinal PTA by FRCs during GVHD resulted in the activation of autoaggressive T cells and gut injury. Finally, we show that FRCs normally expressed a unique PTA gene signature that was highly enriched for genes expressed in the target organs affected by chronic GVHD. In conclusion, acute GVHD damages and prevents repair of the FRC network, thus disabling an essential platform for purging autoreactive T cells from the repertoire.

Authors

Simone Dertschnig, Pamela Evans, Pedro Santos e Sousa, Teresa Manzo, Ivana R. Ferrer, Hans J. Stauss, Clare L. Bennett, Ronjon Chakraverty

×

Figure 7

FRCs express a distinct PTA gene signature enriched for genes normally expressed in target organs of chronic GVHD.

Options: View larger image (or click on image) Download as PowerPoint
FRCs express a distinct PTA gene signature enriched for genes normally e...
(A) Analytical pipeline of FRC-specific PTA candidate.. LNSC, lymph node stromal cell. (B) Correlation matrix of PTA candidates in published gene expression data from different LN stromal cell subsets. Pearson’s correlation coefficient r between the respective subsets is indicated. FRC-enriched PTA genes are highlighted in red. ***P < 0.001, indicating the quality of each measured Pearson’s r between any given subset. (C) Tissue representation of FRC-enriched PTAs (≥3-fold expression compared with other LN stromal cell subsets). As control, a random set of 356 PTAs, which are not enriched in FRCs, was used. (D) Venn diagram showing the overlap between thymic PTAs repressed in GVHD by greater than 3-fold and PTAs identified to be enriched in FRCs compared with other LN stromal subsets. (E) Enrichment of the FRC-enriched PTA gene set was analyzed by GSEA in FRCs isolated from GVHD+ versus GVHD– recipients, or from vaccinated mice in which FRCs selectively lacked IL-17Rα versus wild-type controls, or from HSV-infected versus control noninfected mice.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts